News Focus
News Focus
icon url

Investor2014

04/01/26 10:04 AM

#516646 RE: Hosai #516644

It is clearly important that Anavex designs a trial that could show that blarcamesine improves that pathway.
icon url

tradeherpete

04/01/26 10:54 AM

#516647 RE: Hosai #516644

And as everyone knows, there’s not much better than having a Col24a1 enriched in the subiculum except maybe being able to maintain its volume.

This has to scare the pituitary out of big pharma...